New SDRC Executive Committee Member: Dr Jennifer Macfarlane

New SDRC Executive Committee Member: Dr Jennifer Macfarlane

Given the change of circumstances of the SDRC Executive Committee in 2020/21, the committee have decided to co-opt Jennifer to the Executive to support our growing activities as we emerge from the pandemic. Find out more in Jennifer’s biography below. Jen...
Scottish Neurological Research Fund 2021: Award Announcement

Scottish Neurological Research Fund 2021: Award Announcement

Scottish Neurological Research Fund Announcement   Earlier this year, the Scottish Neurological Research Fund (SNRF) launched a second round of funding, following its success in 2019. The scheme provides up to £15,000 of funding per application for small...

The launch Scottish Brain Health and Dementia Research Strategy

Today (8 July 2021) sees the launch of the first Scottish Brain Health & Dementia Research Strategy. Prepared by Alzheimer Scotland, The Scottish Dementia Research Consortium and Brain Health Scotland, and endorsed by a broad range of national organisations, the...
The launch of the SDRC Annual Report 2020/21

The launch of the SDRC Annual Report 2020/21

The SDRC Annual Report 2020/21, launched at the SDRC Annual Conference 2021 on Wednesday 16th June. It outlines what research has been ongoing in dementia and brain health research in Scotland in the past 12 months. Of course, it heavily features the impact COVID has...
Aducanumab: Approval of new Alzheimer’s disease drug explained

Aducanumab: Approval of new Alzheimer’s disease drug explained

Aducanumab: Dr Terry Quinn explains approval of new Alzheimer’s disease drug  SDRC Executive Committee member, Dr Terry Quinn, Terry takes us through all the important facts behind the recent announcement by the FDA in the US to approve aducanumab for the...